Skip to main content
CRIS
NASDAQ Life Sciences

Stockholders Approve Massive Increase in Authorized Shares and New Equity Incentive Plan

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$0.892
Mkt Cap
$12.246M
52W Low
$0.771
52W High
$3.18
Market data snapshot near publication time

Summary

Curis stockholders approved a massive increase in authorized common stock and a new equity incentive plan, paving the way for significant future dilution.


Key Events

  • Authorized Common Stock Increased

    Stockholders approved an amendment to the Certificate of Incorporation, increasing the number of authorized common shares from 68,343,750 to 283,757,150. This authorizes the company to issue up to an additional 215,413,400 shares.

  • New Equity Incentive Plan Approved

    The 2026 Incentive Plan was approved, initially authorizing 6,407,374 shares for awards, plus up to 3,474,867 shares from a prior plan, and an annual evergreen increase of up to 5% of outstanding shares.

  • Issuance for Existing Convertibles Authorized

    Stockholders approved the issuance of shares upon conversion of Series B Preferred Stock and exercise of Series A, B, and C Warrants, and Pre-Funded Warrants, clearing the way for future dilution from these instruments.


Analysis

Curis, Inc. stockholders have approved a substantial increase in the company's authorized common stock, raising the limit from 68,343,750 to 283,757,150 shares. This represents an increase of over 215 million shares, significantly expanding the company's capacity for future equity issuance. Concurrently, a new 2026 Incentive Plan was approved, authorizing an initial pool of nearly 10 million shares for awards, with an additional annual evergreen provision. These actions, coupled with the authorization to issue shares for existing convertible securities, signal a high likelihood of substantial future dilution for existing shareholders. For a micro-cap company, this level of potential share issuance is a critical event that could significantly impact existing shareholder value, suggesting a need for significant capital raises or conversions.

At the time of this filing, CRIS was trading at $0.89 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.2M. The 52-week trading range was $0.77 to $3.18. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRIS - Latest Insights

CRIS
Jun 05, 2026, 9:06 AM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.499
Real-time Price: $0.4211 info
Change: -$0.0779 (-16%) info
Market Cap: $16.414M info
CRIS
May 22, 2026, 5:05 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.5012
Real-time Price: $0.4211 info
Change: -$0.0801 (-16%) info
Market Cap: $16.414M info
CRIS
May 22, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.5012
Real-time Price: $0.4211 info
Change: -$0.0801 (-16%) info
Market Cap: $16.414M info
CRIS
May 13, 2026, 9:20 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.5204
Real-time Price: $0.4211 info
Change: -$0.0993 (-19%) info
Market Cap: $16.414M info
CRIS
May 12, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.5504
Real-time Price: $0.4211 info
Change: -$0.1293 (-23%) info
Market Cap: $16.414M info
CRIS
May 12, 2026, 4:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.5465
Real-time Price: $0.4211 info
Change: -$0.1254 (-23%) info
Market Cap: $16.414M info
CRIS
May 01, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.592
Real-time Price: $0.4211 info
Change: -$0.1709 (-29%) info
Market Cap: $16.414M info
CRIS
May 01, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.5881
Real-time Price: $0.4211 info
Change: -$0.167 (-28%) info
Market Cap: $16.414M info
CRIS
Apr 21, 2026, 4:52 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.590
Real-time Price: $0.4211 info
Change: -$0.1689 (-29%) info
Market Cap: $16.414M info
CRIS
Apr 10, 2026, 4:19 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.474
Real-time Price: $0.4211 info
Change: -$0.0529 (-11%) info
Market Cap: $16.414M info